Edition:
United Kingdom

Insider Trading: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

33.23USD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
$33.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,047
52-wk High
$54.45
52-wk Low
$27.85

All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 Apr 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,900 $36.27
10 Apr 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,900 $37.04
9 Apr 2019

Kim (Mina)

General Counsel Sell 3,674 $36.85
3 Apr 2019

Newell (Joseph)

Chief Technology Officer Sell 648 $41.04
1 Apr 2019

Newell (Joseph)

Chief Technology Officer Sell 1,500 $39.96
1 Apr 2019

Newell (Joseph)

Chief Technology Officer Buy 1,500 $20.40
29 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 200 $41.70
29 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,700 $39.81
28 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 2,000 $36.75
28 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 1,600 $38.02
28 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 300 $38.59
26 Mar 2019

Newell (Joseph)

Officer Buy 15,000 $0.00
26 Mar 2019

Kim (Mina)

General Counsel Buy 10,000 $0.00
26 Mar 2019

Berger (Dietmar)

Officer Buy 15,000 $0.00
26 Mar 2019

Koppikar (Utpal)

Chief Financial Officer Buy 10,000 $0.00
26 Mar 2019

Porter (Derrell P)

Officer Buy 10,000 $0.00
15 Mar 2019

Marcus (Joel S)

Director Sell 20,000 $38.25
15 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,900 $38.73
14 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,200 $40.48
14 Mar 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 700 $39.10
1 Mar 2019

Newell (Joseph)

Chief Technology Officer Sell 1,300 $36.04
1 Mar 2019

Newell (Joseph)

Chief Technology Officer Buy 1,500 $20.40
1 Mar 2019

Newell (Joseph)

Chief Technology Officer Sell 200 $36.75
28 Feb 2019

Marcus (Joel S)

Director Sell 62,590 $36.07
28 Feb 2019

Ciechanover (Isaac E)

Chief Executive Officer Sell 3,900 $36.13

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 181
Total Shares Held: 51,507,657
3 Mo. Net Change: -28,430
# New Positions: 5
# Closed Positions: 7
# Increased Positions: 9
# Reduced Positions: 16
# Net Buyers: -7

Officers & Directors

Name Age Since Current Position

Isaac Ciechanover

47 2016 Chairman of the Board, President, Chief Executive Officer

Utpal Koppikar

47 2018 Chief Financial Officer

Joseph Newell

48 2017 Executive Vice President, Chief Technical Operations Officer

Christopher Haqq

51 2012 Executive Vice President - Research and Development, Chief Scientific Officer

Mitchall Clark

56 2014 Executive Vice President and Chief Regulatory and Quality Assurance Officer

Gad Soffer

41 2016 Executive Vice President and Chief Strategy Officer

Derrell Porter

47 2017 Senior Vice President,Head of Commercial

Carol Gallagher

53 2013 Lead Independent Director

Roy Baynes

2018 Independent Director

Eric Dobmeier

49 2015 Independent Director

Matthew Fust

53 2014 Independent Director

William Heiden

58 2015 Independent Director

Beth Seidenberg

61 2012 Independent Director

John Craighead

Vice President, Investor Relations